Search

Kamal A. Saeed

Examiner (ID: 13000, Phone: (571)272-0705 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1626
Total Applications
3146
Issued Applications
2344
Pending Applications
317
Abandoned Applications
526

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17110044 [patent_doc_number] => 20210290641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => EP4 INHIBITORS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/187900 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45157 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187900 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/187900
EP4 INHIBITORS AND USE THEREOF Feb 28, 2021 Abandoned
Array ( [id] => 18732582 [patent_doc_number] => 11801302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Formulations and uses thereof [patent_app_type] => utility [patent_app_number] => 17/186548 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 57066 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186548 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/186548
Formulations and uses thereof Feb 25, 2021 Issued
Array ( [id] => 18271628 [patent_doc_number] => 20230092870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => MARGARIC ACID DECREASES PIEZ02-MEDIATED PAIN [patent_app_type] => utility [patent_app_number] => 17/799500 [patent_app_country] => US [patent_app_date] => 2021-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/799500
MARGARIC ACID DECREASES PIEZ02-MEDIATED PAIN Feb 20, 2021 Pending
Array ( [id] => 16946588 [patent_doc_number] => 20210205279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => SOLID DISPERSION FORMS OF RIFAXIMIN [patent_app_type] => utility [patent_app_number] => 17/174829 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11137 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174829 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/174829
Solid dispersion forms of rifaximin Feb 11, 2021 Issued
Array ( [id] => 18337796 [patent_doc_number] => 20230129745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC DISEASE [patent_app_type] => utility [patent_app_number] => 17/760093 [patent_app_country] => US [patent_app_date] => 2021-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760093 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/760093
COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC DISEASE Feb 7, 2021 Pending
Array ( [id] => 17065775 [patent_doc_number] => 20210267990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => METHOD FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/167200 [patent_app_country] => US [patent_app_date] => 2021-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17167200 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/167200
METHOD FOR TREATING CANCER Feb 3, 2021 Abandoned
Array ( [id] => 17314964 [patent_doc_number] => 20210404012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => INHIBITOR OF ATR KINASE FOR USE IN A METHOD OF TREATING A HYPER-PROLIFERATIVE DISEASE [patent_app_type] => utility [patent_app_number] => 17/164336 [patent_app_country] => US [patent_app_date] => 2021-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32742 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164336 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/164336
Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease Jan 31, 2021 Issued
Array ( [id] => 17014075 [patent_doc_number] => 11083694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-10 [patent_title] => Injectable phenol formulations and methods of their use [patent_app_type] => utility [patent_app_number] => 17/160951 [patent_app_country] => US [patent_app_date] => 2021-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9858 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160951 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/160951
Injectable phenol formulations and methods of their use Jan 27, 2021 Issued
Array ( [id] => 17014076 [patent_doc_number] => 11083695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-10 [patent_title] => Injectable phenol formulations and methods of manufacture [patent_app_type] => utility [patent_app_number] => 17/160993 [patent_app_country] => US [patent_app_date] => 2021-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9896 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160993 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/160993
Injectable phenol formulations and methods of manufacture Jan 27, 2021 Issued
Array ( [id] => 16837778 [patent_doc_number] => 20210145790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => METHOD FOR PROVIDING EARLY ONSET OF ACTION IN THE TREATMENT OF ROSACEA [patent_app_type] => utility [patent_app_number] => 17/156941 [patent_app_country] => US [patent_app_date] => 2021-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11446 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156941 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/156941
Method for providing early onset of action in the treatment of rosacea Jan 24, 2021 Issued
Array ( [id] => 18836747 [patent_doc_number] => 11844804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-19 [patent_title] => Administration of testosterone compositions [patent_app_type] => utility [patent_app_number] => 17/157310 [patent_app_country] => US [patent_app_date] => 2021-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 22900 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157310 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/157310
Administration of testosterone compositions Jan 24, 2021 Issued
Array ( [id] => 19026313 [patent_doc_number] => 11925653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-12 [patent_title] => Combination therapy effective against microorganisms, including drug resistant microorganisms [patent_app_type] => utility [patent_app_number] => 17/157993 [patent_app_country] => US [patent_app_date] => 2021-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17408 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157993 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/157993
Combination therapy effective against microorganisms, including drug resistant microorganisms Jan 24, 2021 Issued
Array ( [id] => 18886344 [patent_doc_number] => 11865100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Method for treatment of rosacea in patients aged 65 years and older [patent_app_type] => utility [patent_app_number] => 17/154689 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9945 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154689 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/154689
Method for treatment of rosacea in patients aged 65 years and older Jan 20, 2021 Issued
Array ( [id] => 18916691 [patent_doc_number] => 11878961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-23 [patent_title] => Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer [patent_app_type] => utility [patent_app_number] => 17/153340 [patent_app_country] => US [patent_app_date] => 2021-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 47 [patent_no_of_words] => 8972 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153340 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/153340
Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer Jan 19, 2021 Issued
Array ( [id] => 18762870 [patent_doc_number] => 11813249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-14 [patent_title] => Combination therapy for treatment of restenosis [patent_app_type] => utility [patent_app_number] => 17/149631 [patent_app_country] => US [patent_app_date] => 2021-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 51 [patent_no_of_words] => 27530 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149631 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/149631
Combination therapy for treatment of restenosis Jan 13, 2021 Issued
Array ( [id] => 18799986 [patent_doc_number] => 11833129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Thiophene compound for treatment of exfoliating glaucoma [patent_app_type] => utility [patent_app_number] => 17/149549 [patent_app_country] => US [patent_app_date] => 2021-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 20 [patent_no_of_words] => 15407 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149549 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/149549
Thiophene compound for treatment of exfoliating glaucoma Jan 13, 2021 Issued
Array ( [id] => 16969272 [patent_doc_number] => 11065218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-20 [patent_title] => Compositions and methods for treating chronic inflammation and inflammatory diseases [patent_app_type] => utility [patent_app_number] => 17/146950 [patent_app_country] => US [patent_app_date] => 2021-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 37225 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146950 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/146950
Compositions and methods for treating chronic inflammation and inflammatory diseases Jan 11, 2021 Issued
Array ( [id] => 17074840 [patent_doc_number] => 11111224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-07 [patent_title] => Benzothia(di)azepine compounds and their use as bile acid modulators [patent_app_type] => utility [patent_app_number] => 17/144568 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33125 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144568 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/144568
Benzothia(di)azepine compounds and their use as bile acid modulators Jan 7, 2021 Issued
Array ( [id] => 16946559 [patent_doc_number] => 20210205250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT [patent_app_type] => utility [patent_app_number] => 17/140733 [patent_app_country] => US [patent_app_date] => 2021-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6606 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140733 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/140733
CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT Jan 3, 2021 Abandoned
Array ( [id] => 19490595 [patent_doc_number] => 12109280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-08 [patent_title] => Oil-in-water emulsion comprising an amphiphilic polymer [patent_app_type] => utility [patent_app_number] => 17/140720 [patent_app_country] => US [patent_app_date] => 2021-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17795 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140720 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/140720
Oil-in-water emulsion comprising an amphiphilic polymer Jan 3, 2021 Issued
Menu